CD8A and neoplasm: Importantly, propranolol was found to decrease the expression of programmed death receptor-1 (PD-1) in tumours and to increase CD8 + T cell infiltration within the tumour microenvironment, thus enhancing the efficacy of immune checkpoint blockade (Bucsek et al. 2017; Yan et al. 2022).